Cargando…
Serum a‐1 antitrypsin as a novel biomarker in chronic heart failure
AIMS: Chronic heart failure (CHF) remains a major health issue worldwide. In the present study, we aimed to identify novel circulating biomarkers for CHF using serum proteomics technology and to validate the biomarker in three independent cohorts. METHODS AND RESULTS: The isobaric tags for relative...
Autores principales: | Zheng, Ying‐Ying, Wu, Ting‐Ting, Hou, Xian‐Geng, Yang, Hai‐Tao, Yang, Yi, Xiu, Wen‐Juan, Pan, Ying, Ma, Yi‐Tong, Mahemuti, Ailiman, Xie, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567649/ https://www.ncbi.nlm.nih.gov/pubmed/37417425 http://dx.doi.org/10.1002/ehf2.14451 |
Ejemplares similares
-
Correlation Study of the Long-Term Prognosis of Venous Thromboembolism and Inflammatory Gene Polymorphisms
por: Abuduhalike, Refukaiti, et al.
Publicado: (2020) -
Hemoglobin-to-Red-Cell Distribution Width Ratio Is a Novel Predictor of Long-Term Patient Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study
por: Xiu, Wen-Juan, et al.
Publicado: (2022) -
Resting Heart Rate and Long-Term Outcomes in Patients with Percutaneous Coronary Intervention: Results from a 10-Year Follow-Up of the CORFCHD-PCI Study
por: Zheng, Ying-Ying, et al.
Publicado: (2019) -
Mutated CYP17A1 promotes atherosclerosis and early-onset coronary artery disease
por: Wu, Ting-Ting, et al.
Publicado: (2023) -
ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
por: Xiu, Wen-Juan, et al.
Publicado: (2022)